The Caledonian-Record

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying ...
The Caledonian-Record

Ambiq Announces Closing of its Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BofA Securities and UBS Investment Bank acted as joint lead book-running managers for the offering. Needham & Company, Stifel, and Roth Capital Partners acted as joint book-running managers for the ...